GEN Protocols
From the publisher of Genetic Engineering & Biotechnology News, a dynamic new hub for editorially curated, freely accessible scientific protocols, protocol preprints, software tools, and technical tips & tricks in biotechnology
From the publisher of Genetic Engineering & Biotechnology News, a dynamic new hub for editorially curated, freely accessible scientific protocols, protocol preprints, software tools, and technical tips & tricks in biotechnology
Researchers say there is little chance of a virus mutating to avoid this vaccination strategy, which blocks viral ability to suppress host RNAi responses.
Researchers say there is little chance of a virus mutating to avoid this vaccination strategy, which blocks viral ability to suppress host RNAi responses.
By capturing the genotypic and phenotypic heterogeneity of real tissues, organoids faithfully model human diseases and therapeutic responses.
A new study shows tetracycline antibiotics help the immune system find cancer cells in a way that is different from current immunotherapies.
SPARDA and other systems that encode diverse effectors have the potential to offer a novel programmable tool for the field of biotechnology.
The past two years have seen exciting advances in the world of genomics, as several companies threaten to disrupt the next-gen sequencing (NGS) establishment. Meanwhile,…
On this week’s Touching Base podcast, the GEN editors discuss the launch of Nvelop Therapeutics, a new start-up leveraging approaches developed by gene editing pioneers David…
© 2024 Mary Ann Liebert, Inc. Publishers. All rights reserved.
The past two years have seen exciting advances in the world of genomics, as several companies threaten to disrupt the next-gen sequencing (NGS) establishment. Meanwhile,…
Researchers say there is little chance of a virus mutating to avoid this vaccination strategy, which blocks viral ability to suppress host RNAi responses.